There were 122 National Labor Relations Board representation elections run in February 2025, and ten involved units of 250 or ...

UnitedHealth Group stands out as a solid investment choice amidst financial uncertainty. With an equity beta of 0.67, it ...

RiverPark Advisors, an investment advisory firm and sponsor of the RiverPark family of mutual funds, released its “RiverPark ...

His parents have now filed a lawsuit against both the pharmacy benefits-management company and Walgreens, claiming they are responsible for their son's death. The Schmidtknechts' ...

Vertex's Journavx, a new non-opioid pain drug, lands Tier 3 on Optum Rx formularies. Vertex reports $2.91 billion Q4 sales.

The Boston-based company's new medication, called Journavx, is being placed on a tier that means it might be costlier than ...

Vertex Pharma (VRTX) stock slips as UnitedHealth (UNH) offers its pain drug Journavx Tier 3 coverage, setting a rivalry with ...

Polen Capital, an investment management company, released its “Polen Focus Growth Strategy” fourth quarter 2024 investor ...

These changes are part of ongoing efforts to reduce total UnitedHealthcare prior authorization volume," the company said.

UnitedHealth Group faced two new investigations from federal lawmakers. The first was a senator’s probe into its Medicare ...

The deal requires the defendants to pay $4.8 million—$4.6 million from Aetna and $200,000 from Optum—into a settlement fund that will be used to compensate individual patients and health plans for the ...